Clinical Trial Update: Sevoflurane- Safety in Long-term Sedation Procedures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial on sevoflurane safety during long-term sedation procedures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fluoride Poisoning
• Hepatic Function
• Poisoning By Inhaled Anaesthetic
• Recovery From Sedation
• Renal Function

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: F Javier Belda | Conditions: Poisoning by Inhaled Anaesthetic, Fluoride Poisoning | Phase 3 | Status: WITHDRAWN